These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17038033)

  • 1. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis.
    Visser LH
    Eur J Neurol; 2006 Nov; 13(11):1203-12. PubMed ID: 17038033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Critical-illness" polyneuropathy and -myopathy].
    Leijten FS; de Letter MA; Op de Coul AA
    Ned Tijdschr Geneeskd; 2000 Jul; 144(30):1428-32. PubMed ID: 10932694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical illness polyneuropathy and myopathy in pediatric intensive care: A review.
    Williams S; Horrocks IA; Ouvrier RA; Gillis J; Ryan MM
    Pediatr Crit Care Med; 2007 Jan; 8(1):18-22. PubMed ID: 17251877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course.
    Ahlbeck K; Fredriksson K; Rooyackers O; Måbäck G; Remahl S; Ansved T; Eriksson L; Radell P
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):717-23. PubMed ID: 19388901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical illness polyneuromyopathy (CIPNM); rehabilitation during critical illness. Therapeutic options in nursing to promote recovery: a review of the literature.
    Doherty N; Steen CD
    Intensive Crit Care Nurs; 2010 Dec; 26(6):353-62. PubMed ID: 20971010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular manifestations of critical illness.
    Bolton CF
    Muscle Nerve; 2005 Aug; 32(2):140-63. PubMed ID: 15825186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial.
    Brunner R; Rinner W; Haberler C; Kitzberger R; Sycha T; Herkner H; Warszawska J; Madl C; Holzinger U
    Crit Care; 2013 Oct; 17(5):R213. PubMed ID: 24088271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular complications of critical illness.
    Osias J; Manno E
    Crit Care Clin; 2014 Oct; 30(4):785-94. PubMed ID: 25257741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICU-acquired weakness.
    Schweickert WD; Hall J
    Chest; 2007 May; 131(5):1541-9. PubMed ID: 17494803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuromuscular complications of sepsis: "Critical illness" polyneuropathy and myopathy].
    Hund E
    Dtsch Med Wochenschr; 2006 Dec; 131(49):2779-82. PubMed ID: 17136659
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intensive care unit-acquired weakness: development of polyneuropathy and myopathy in critically ill patients].
    Takei T
    Brain Nerve; 2014 Feb; 66(2):161-70. PubMed ID: 24523314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the development of polyneuropathy and myopathy in critically ill patients.
    de Letter MA; Schmitz PI; Visser LH; Verheul FA; Schellens RL; Op de Coul DA; van der Meché FG
    Crit Care Med; 2001 Dec; 29(12):2281-6. PubMed ID: 11801825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular disorders in critical illness.
    Pandit L; Agrawal A
    Clin Neurol Neurosurg; 2006 Oct; 108(7):621-7. PubMed ID: 16730883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuromuscular manifestations in critically ill patients].
    Smith TA; Fabricius ME
    Ugeskr Laeger; 2007 Jun; 169(23):2216-9. PubMed ID: 17592690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical illness associated neuromuscular disorders -- keep them in mind.
    Nemes R; Molnár L; Fülep Z; Fekete K; Berhés M; Fülesdi B
    Ideggyogy Sz; 2014 Nov; 67(11-12):364-75. PubMed ID: 25720238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical illness polyneuromyopathy.
    Confer J; Wolcott J; Hayes R
    Am J Health Syst Pharm; 2012 Jul; 69(14):1199-205. PubMed ID: 22761073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical consequences of neuromuscular impairments in critically ill patients].
    Mesejo A; Pérez-Sancho E; Moreno E
    Nutr Hosp; 2006 May; 21 Suppl 3():104-13. PubMed ID: 16768037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrodiagnostic findings in patients with non-COVID-19- and COVID-19-related acute respiratory distress syndrome.
    Scarpino M; Bonizzoli M; Lazzeri C; Lanzo G; Lolli F; Ciapetti M; Hakiki B; Grippo A; Peris A; ; Ammannati A; Baldanzi F; Bastianelli M; Bighellini A; Boccardi C; Carrai R; Cassardo A; Cossu C; Gabbanini S; Ielapi C; Martinelli C; Masi G; Mei C; Troiano S
    Acta Neurol Scand; 2021 Aug; 144(2):161-169. PubMed ID: 33890282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.
    Latronico N; Bolton CF
    Lancet Neurol; 2011 Oct; 10(10):931-41. PubMed ID: 21939902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic aspects of critical illness polyneuromyopathy.
    Hermans G; Vanhorebeek I; Derde S; Van den Berghe G
    Crit Care Med; 2009 Oct; 37(10 Suppl):S391-7. PubMed ID: 20046125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.